Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Rating of "Moderate Buy" from Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) has been given an average rating of "Moderate Buy" by the ten ratings firms that are covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $36.56.

SGRY has been the subject of several research reports. Macquarie reaffirmed an "outperform" rating and set a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. Bank of America initiated coverage on Surgery Partners in a research note on Monday, December 16th. They issued a "buy" rating and a $30.00 price objective on the stock. UBS Group began coverage on Surgery Partners in a research note on Monday, October 14th. They set a "buy" rating and a $38.00 price target on the stock. KeyCorp initiated coverage on Surgery Partners in a research note on Friday, October 11th. They issued a "sector weight" rating on the stock. Finally, JPMorgan Chase & Co. lowered their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a report on Tuesday, December 3rd.

Hedge Funds Weigh In On Surgery Partners

Institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC grew its holdings in Surgery Partners by 3.1% in the 3rd quarter. FMR LLC now owns 18,311,867 shares of the company's stock worth $590,375,000 after acquiring an additional 546,869 shares during the last quarter. Janus Henderson Group PLC lifted its position in Surgery Partners by 27.5% during the 3rd quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company's stock valued at $177,235,000 after acquiring an additional 1,184,450 shares during the period. Geode Capital Management LLC lifted its position in Surgery Partners by 2.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company's stock valued at $60,117,000 after acquiring an additional 42,897 shares during the period. King Street Capital Management L.P. purchased a new position in Surgery Partners during the 3rd quarter valued at about $46,748,000. Finally, Victory Capital Management Inc. lifted its position in Surgery Partners by 140.4% during the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company's stock valued at $42,892,000 after acquiring an additional 777,038 shares during the period.

Surgery Partners Stock Up 0.4 %

NASDAQ SGRY traded up $0.09 during trading hours on Friday, reaching $25.79. 1,082,163 shares of the company's stock were exchanged, compared to its average volume of 1,660,259. The company's 50-day moving average is $21.76 and its two-hundred day moving average is $26.99. Surgery Partners has a one year low of $19.50 and a one year high of $35.29. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company has a market capitalization of $3.28 billion, a price-to-earnings ratio of -53.73, a price-to-earnings-growth ratio of 17.66 and a beta of 2.60.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company's quarterly revenue was up 14.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.15 EPS. On average, analysts forecast that Surgery Partners will post 0.71 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.